Lipid Absorption Triggers Drug Supersaturation at the Intestinal Unstirred Water Layer and Promotes Drug Absorption from Mixed Micelles
To evaluate the potential for the acidic intestinal unstirred water layer (UWL) to induce drug supersaturation and enhance drug absorption from intestinal mixed micelles, via the promotion of fatty acid absorption.
Using a single-pass rat jejunal perfusion model, the absorptive-flux of cinnarizine and 3H-oleic acid from oleic acid-containing intestinal mixed micelles was assessed under normal acidic microclimate conditions and conditions where the acidic microclimate was attenuated via the co-administration of amiloride. As a control, the absorptive-flux of cinnarizine from micelles of Brij® 97 (a non-ionizable, non-absorbable surfactant) was assessed in the absence and presence of amiloride. Cinnarizine solubility was evaluated under conditions of decreasing pH and decreasing micellar lipid content to assess likely changes in solubilization and thermodynamic activity during micellar passage across the UWL.
In the presence of amiloride, the absorptive-flux of cinnarizine and 3H-oleic acid from mixed micelles decreased 6.5-fold and 3.0-fold, respectively. In contrast, the absorptive-flux of cinnarizine from Brij® 97 micelles remained unchanged by amiloride, and was significantly lower than from the long-chain micelles. Cinnarizine solubility in long-chain micelles decreased under conditions where pH and micellar lipid content decreased simultaneously.
The acidic microclimate of the intestinal UWL promotes drug absorption from intestinal mixed micelles via the promotion of fatty acid absorption which subsequently stimulates drug supersaturation. The observations suggest that formulations (or food) containing absorbable lipids (or their digestive precursors) may outperform formulations that lack absorbable components since the latter do not benefit from lipid absorption-induced drug supersaturation.
Key wordsabsorption food effect lipid based formulations poorly water soluble drug supersaturation unstirred water layer
Cluster of Differentiation 36
fatty acid transport protein
high performance liquid chromatography
Lipid based formulation
long-chain fatty acid
Lipid Formulation Classification System
poorly water-soluble drugs
simulated endogenous intestinal fluid
Scavenger Receptor Class B Type I
unstirred water layer
Acknowledgments and Disclosures
Funding support from the National Health and Medical Research Council (NHMRC) of Australia is gratefully acknowledged.
- 7.Anby MU, Williams HD, McIntosh M, Benameur H, Edwards GA, Pouton CW, et al. Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems. Mol Pharm. 2012;9(7):2063–79.CrossRefGoogle Scholar
- 8.Williams HD, Anby MU, Sassene P, Kleberg K, Bakala-N’Goma J-C, Calderone M, et al. Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of Type I, II, IIIA, IIIB, and IV formulations during in vitro digestion. Mol Pharm. 2012;9(11):3286–300.PubMedCrossRefGoogle Scholar
- 9.Williams HD, Sassene P, Kleberg K, Calderone M, Igonin A, Jule E, et al. Toward the establishment of standardized in vitro tests for lipid-based formulations: 3) Understanding supersaturation versus precipitation potential during the in vitro digestion of Type I, II, IIIA, IIIB and IV lipid-based formulations. Pharmaceutical Research. 2013. doi: 10.1007/s11095-013-1038-z.
- 11.Yeap YY, Trevaskis NL, Porter CJH. The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs. Molecular Pharmaceutics. 2013. doi: 10.1021/mp400035z.
- 17.Shiau YF, Fernandez P, Jackson MJ, McMonagle S. Mechanisms maintaining a low-pH microclimate in the intestine. Am J Physiol Gastrointest Liver Physiol. 1985;248(6):G608–17.Google Scholar
- 19.Shiau YF, Kelemen RJ, Reed MA. Acidic mucin layer facilitates micelle dissociation and fatty acid diffusion. Am J Physiol Gastrointest Liver Physiol. 1990;259(4):G671–5.Google Scholar
- 25.Williams HD, Sassene P, Kleberg K, Bakala-N'Goma J-C, Calderone M, Jannin V, et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations. J Pharm Sci. 2012;101(9):3360–80.PubMedCrossRefGoogle Scholar
- 39.Hofmann AF. Molecular association in fat digestion. Molecular Association in Biological and Related Systems: American Chemical Society; 1968. p. 53–66.Google Scholar
- 44.Williams HD, Trevaskis NL, Pouton CW, Porter CJH. Lipid-based formulations and drug supersaturation: Harnessing the unique benefits of the lipid digestion/absorption pathway. Pharm Res. 2013 (in press, this issue).Google Scholar